(Q54377067)

English

The carboxylic ionophore monensin inhibits active drug efflux and modulates in vitro resistance in daunorubicin resistant Ehrlich ascites tumor cells

scientific article published on September 1, 1988

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3401258

The carboxylic ionophore monensin inhibits active drug efflux and modulates in vitro resistance in daunorubicin resistant Ehrlich ascites tumor cells (English)

1 reference

10.1016/0006-2952(88)90643-0

https://api.crossref.org/works/10.1016/0006-2952(88)90643-0

6 January 2023

1 reference

based on heuristic

inferred from title

1 reference

10.1016/0006-2952(88)90643-0

https://api.crossref.org/works/10.1016/0006-2952(88)90643-0

6 January 2023

1 reference

10.1016/0006-2952(88)90643-0

https://api.crossref.org/works/10.1016/0006-2952(88)90643-0

6 January 2023

author name string

M. Sehested

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3401258

6 January 2023

T. Skovsgaard

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3401258

6 January 2023

H. Roed

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3401258

6 January 2023

language of work or name

0 references

publication date

1 September 1988

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3401258

full work available at URL

https://api.elsevier.com/content/article/PII:0006295288906430?httpAccept=text/xml

1 reference

10.1016/0006-2952(88)90643-0

https://api.crossref.org/works/10.1016/0006-2952(88)90643-0

6 January 2023

https://api.elsevier.com/content/article/PII:0006295288906430?httpAccept=text/plain

1 reference

10.1016/0006-2952(88)90643-0

https://api.crossref.org/works/10.1016/0006-2952(88)90643-0

6 January 2023

Biochemical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3401258

37

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3401258

17

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3401258

3305-3310

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3401258

Tumour cell resistance to anthracyclines--a review

1

1 reference

10.1016/0006-2952(88)90643-0

https://api.crossref.org/works/10.1016/0006-2952(88)90643-0

6 January 2023

Mechanisms of resistance to daunorubicin in Ehrlich ascites tumor cells

2

1 reference

10.1016/0006-2952(88)90643-0

https://api.crossref.org/works/10.1016/0006-2952(88)90643-0

6 January 2023

Mechanism of cross-resistance between vincristine and daunorubicin in Ehrlich ascites tumor cells

3

1 reference

10.1016/0006-2952(88)90643-0

https://api.crossref.org/works/10.1016/0006-2952(88)90643-0

6 January 2023

The cell biology of multiple drug resistance

4

1 reference

10.1016/0006-2952(88)90643-0

https://api.crossref.org/works/10.1016/0006-2952(88)90643-0

6 January 2023

Perturbation of vesicular traffic with the carboxylic ionophore monensin

5

1 reference

10.1016/0006-2952(88)90643-0

https://api.crossref.org/works/10.1016/0006-2952(88)90643-0

6 January 2023

Development of resistance to daunomycin (NSC-82151) in Ehrlich ascites tumor

6

1 reference

10.1016/0006-2952(88)90643-0

https://api.crossref.org/works/10.1016/0006-2952(88)90643-0

6 January 2023

Inter-experiment variation and dependence on culture conditions in assaying the chemosensitivity of human small cell lung cancer cell lines.

7

1 reference

10.1016/0006-2952(88)90643-0

https://api.crossref.org/works/10.1016/0006-2952(88)90643-0

6 January 2023

Transport and binding of daunorubicin, adriamycin, and rubidazone in ehrlich ascites tumour cells

9

1 reference

10.1016/0006-2952(88)90643-0

https://api.crossref.org/works/10.1016/0006-2952(88)90643-0

6 January 2023

Carrier-mediated transport of daunorubicin, adriamycin, and rubidazone in ehrlich ascites tumour cells

10

1 reference

10.1016/0006-2952(88)90643-0

https://api.crossref.org/works/10.1016/0006-2952(88)90643-0

6 January 2023

Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia

12

1 reference

10.1016/0006-2952(88)90643-0

https://api.crossref.org/works/10.1016/0006-2952(88)90643-0

6 January 2023

Cellular transport of anthracyclines by passive diffusion. Implications for drug resistance.

13

1 reference

10.1016/0006-2952(88)90643-0

https://api.crossref.org/works/10.1016/0006-2952(88)90643-0

6 January 2023

Increase in nonspecific adsorptive endocytosis in anthracycline- and vinca alkaloid-resistant Ehrlich ascites tumor cell lines.

14

1 reference

10.1016/0006-2952(88)90643-0

https://api.crossref.org/works/10.1016/0006-2952(88)90643-0

6 January 2023

Increased plasma membrane traffic in daunorubicin resistant P388 leukaemic cells. Effect of daunorubicin and verapamil

15

1 reference

10.1016/0006-2952(88)90643-0

https://api.crossref.org/works/10.1016/0006-2952(88)90643-0

6 January 2023

Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil

16

1 reference

10.1016/0006-2952(88)90643-0

https://api.crossref.org/works/10.1016/0006-2952(88)90643-0

6 January 2023

Effect of verapamil on daunorubicin accumulation in Ehrlich ascites tumor cells.

18

1 reference

10.1016/0006-2952(88)90643-0

https://api.crossref.org/works/10.1016/0006-2952(88)90643-0

6 January 2023

Correlation between potency of calmodulin inhibitors and effects on cellular levels and cytotoxic activity of doxorubicin (adriamycin) in resistant P388 mouse leukemia cells

19

1 reference

10.1016/0006-2952(88)90643-0

https://api.crossref.org/works/10.1016/0006-2952(88)90643-0

6 January 2023

Chloroquine enhancement of anticancer drug cytotoxicity in multiple drug resistant human leukemic cells

20

1 reference

10.1016/0006-2952(88)90643-0

https://api.crossref.org/works/10.1016/0006-2952(88)90643-0

6 January 2023

Lysosomotropic agents reverse multiple drug resistance in human cancer cells

21

1 reference

10.1016/0006-2952(88)90643-0

https://api.crossref.org/works/10.1016/0006-2952(88)90643-0

6 January 2023

Effects of exogenous amines on mammalian cells, with particular reference to membrane flow

22

1 reference

10.1016/0006-2952(88)90643-0

https://api.crossref.org/works/10.1016/0006-2952(88)90643-0

6 January 2023

Biological applications of ionophores

23

1 reference

10.1016/0006-2952(88)90643-0

https://api.crossref.org/works/10.1016/0006-2952(88)90643-0

6 January 2023

Stimulation of the release of two glycoproteins from mouse 3T3 cells by growth factors and by agents that increase intralysosomal pH.

24

1 reference

10.1016/0006-2952(88)90643-0

https://api.crossref.org/works/10.1016/0006-2952(88)90643-0

6 January 2023

Control of free cytoplasmic calcium by intracellular pH in rat lymphocytes

25

1 reference

10.1016/0006-2952(88)90643-0

https://api.crossref.org/works/10.1016/0006-2952(88)90643-0

6 January 2023

Regulation of Na+/H+ exchange in lymphocytes

26

1 reference

10.1016/0006-2952(88)90643-0

https://api.crossref.org/works/10.1016/0006-2952(88)90643-0

6 January 2023

Thirteen cationic ionophores: their acute toxicity, neurobehavioral and membrane effects

27

1 reference

10.1016/0006-2952(88)90643-0

https://api.crossref.org/works/10.1016/0006-2952(88)90643-0

6 January 2023

Cytotoxicity of compounds that interfere with the regulation of intracellular pH: a potential new class of anticancer drugs

28

1 reference

10.1016/0006-2952(88)90643-0

https://api.crossref.org/works/10.1016/0006-2952(88)90643-0

6 January 2023

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

29

1 reference

10.1016/0006-2952(88)90643-0

https://api.crossref.org/works/10.1016/0006-2952(88)90643-0

6 January 2023

Identifiers

10.1016/0006-2952(88)90643-0

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3401258

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/3401258

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54377067&oldid=2077017559"